Norway· NO-ID_5F7CB944-9011-4959-92D4-9D4982FCE810

Antrolin

A lidocaine product containing nifedipine + lidocaine hydrochloride, registered in Norway by Neopharmed Gentili. The same ATC class is registered in 10 of our 19 countries.

ATC C05AD01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedAntrolinATCC05AD01REGISTER NO.NO-ID_5F7CB944-9011-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Lidocaine is registered in 10 of 19 countries.

Countries holding a registration under ATC C05AD01 (lidocaine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Lidocaine · ATC C05AD01

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Nifedipine + Lidocaine Hydrochloride
Manufacturer
Neopharmed Gentili
Country
Norway (NO)
ATC code
C05AD01
ATC class
Lidocaine
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_varenummer
    266071
    30
  • no_merkevare_id
    ID_5F7CB944-9011-4959-92D4-9D4982FCE810

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for lidocaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lidocaine · interactions on record

39 records

  • 1 severe
  • 38 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lidocaine in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • France · Nifexine
  • Greece · Anusfelia, Zaroco
  • Hungary · Patiox
  • Italy · Antrolin
  • Malta · Antrolin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d03bb2fc-ae8d-459d-a0a0-2a1fe6433762
GET /v1/drugs/d03bb2fc-ae8d-459d-a0a0-2a1fe6433762?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Rektalkrem",
  "source": "fest",
  "status": "A",
  "atc_name": "Lidokain",
  "merkevare_id": "ID_5F7CB944-9011-4959-92D4-9D4982FCE810",
  "name_form_strength": "Antrolin rektalkrem 0,3 % w/w/1,5 % w/w",
  "prescription_group": "C"
}

See everything about lidocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.